Stocks slipped on Tuesday as investors digested a sharp rebound from a strong sell-off last week.US Marketsread more
An under-the-radar hedge fund is ruling the industry with a nearly 30% return this year so far, and it's more than doubling its bet on gold.Marketsread more
The National Rifle Association is turning to old stock footage of Dana Loesch, their former spokeswoman, to rally supporters in the wake of the recent mass shootings and...Politicsread more
The launch follows a "preview" earlier this month that allowed only limited customers to apply.Technologyread more
"The hawks on the Fed are going to be gunning for no more rate cuts, which is obviously not what the market wants," says CNBC's Jim Cramer.Marketsread more
U.S. interest rates will keep falling and follow global interest rates all the way down to zero, hedge fund manager Kyle Bass said.Marketsread more
Lyft's earlier-than-anticipated share lockup expiration could actually serve to boost the ride-sharing company's stock, says trading expert Dan Nathan.Options Actionread more
Plaintiff Patricia Schmitz will be awarded $4.8 million in damages from each company, J&J said. Schmitz said she developed mesothelioma after using both J&J's baby powder and Colgate's Cashmere Bouquet. She was not awarded punitive damages.
The ruling was another setback for J&J. The consumer products company, which makes everything from Tylenol to Aveeno lotions, faces more than 13,000 talc-related lawsuits. Just two weeks ago, J&J was ordered to pay $300 million in punitive damages to a woman in New York who blamed her cancer on the company's talc products. That same day jurors in a similar case in South Carolina cleared the company of liability.
J&J denies allegations that its talc causes cancer. It said numerous studies and tests by regulators worldwide have shown that its talc is safe and asbestos-free.
"We will pursue an appeal because Johnson's Baby Powder does not contain asbestos or cause cancer, as supported by decades of independent clinical evidence," a spokesperson for J&J said in a statement. "There were serious procedural and evidentiary errors in the proceeding that required us to move for mistrial on multiple occasions and we believe provide strong grounds for appeal."
A spokesperson for Colgate said that the "trial suffered from numerous significant legal and evidentiary errors that we believe unfairly prejudiced the defense." The person did not say whether the company would pursue an appeal.
J&J relaunched its iconic namesake baby product line last summer to reverse a decline in the company's baby care unit. While trusted for decades, the 124-year-old brand had fallen out of touch with consumers, namely millennial moms, who have been increasingly opting for upstart brands with a trendier, more natural image.
— CNBC's Angelica LaVito contributed to this report.